Literature DB >> 6404002

HLA and Gm genes in systemic lupus erythematosus.

S Whittingham, J D Mathews, M S Schanfield, B D Tait, I R Mackay.   

Abstract

HLA and Gm phenotypes were compared in 53 patients with unequivocal systemic lupus erythematosus (SLE) and in 180 healthy subjects. SLE was associated with HLA-B8 (relative risk (RR) = 3.5, P less than 0.001) and with HLA-DR3 (RR = 2.8, P less than 0.01). There was an increased risk of SLE with HLA-B8/B27 (RR = 27.6) and with HLA-B15/B35 (RR greater than 13) and, in contrast, the risk was decreased in subjects with HLA-B40 (RR = 0.3). The risk of SLE in subjects who were heterozygous for the Gm phenotypes a,f,x; b,g was increased (RR = 2.0, P = 0.03) relative to the risk in subjects who were homozygous for these Gm phenotypes. These findings suggest that susceptibility to SLE is influenced by one or more genes in linkage disequilibrium with the HLA-B8-DR3 haplotype, by "augmentor" or "protector" genes associated with other HLA antigens and by separate genes, possibly VH genes, in linkage disequilibrium with the Gm (CH allotype) locus.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6404002     DOI: 10.1111/j.1399-0039.1983.tb00372.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  13 in total

Review 1.  Gm allotype system and autoimmune diseases.

Authors:  M Abu-Shakra; Y Shoenfeld
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

2.  Immunoglobulin GM and KM genotypes in Korean patients with systemic lupus erythematosus.

Authors:  E B Lee; Y J Lee; D H Shin; Y M Choi; M H Park; J P Pandey; Y W Song
Journal:  Rheumatol Int       Date:  2006-08-31       Impact factor: 2.631

Review 3.  Systemic lupus erythematosus: RNA-protein autoantigens, models of disease heterogeneity, and theories of etiology.

Authors:  J B Harley; R H Scofield
Journal:  J Clin Immunol       Date:  1991-11       Impact factor: 8.317

4.  Immunoglobulin allotype gene polymorphisms in systemic sclerosis: interactive effect of MHC class II and KM genes on anticentromere antibody production.

Authors:  H Kameda; J P Pandey; J Kaburaki; H Inoko; M Kuwana
Journal:  Ann Rheum Dis       Date:  1998-06       Impact factor: 19.103

5.  Association of class I, II, and III MHC gene products with systemic lupus erythematosus. Results of a Central European multicenter study.

Authors:  K Hartung; A Fontana; M Klar; H Krippner; K Jörgens; B Lang; H H Peter; W J Pichler; D Schendel; M Robin-Winn
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

6.  Immunoglobulin allotype Gm(1,2;21) in ankylosing spondylitis with peripheral arthritis.

Authors:  R Mierau; C A von Mühlen; H Zarnowski; E Genth; P W Hartl
Journal:  Ann Rheum Dis       Date:  1988-11       Impact factor: 19.103

7.  Genetic risk factors in diabetic retinopathy.

Authors:  L L Stewart; L L Field; S Ross; R G McArthur
Journal:  Diabetologia       Date:  1993-12       Impact factor: 10.122

8.  Immunoglobulin allotypes are not associated with HLA-antigens, autoantibodies and clinical symptoms in systemic lupus erythematosus. Members of the SLE Study Group.

Authors:  K Hartung; R Coldewey; E Röther; K Pirner; C Specker; D Schendel; W Stangel; S Stannat-Kiessling; G G de Lange
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

9.  The mapping of the human 52-kD Ro/SSA autoantigen gene to human chromosome 11, and its polymorphisms.

Authors:  M B Frank; K Itoh; A Fujisaku; P Pontarotti; M G Mattei; B R Neas
Journal:  Am J Hum Genet       Date:  1993-01       Impact factor: 11.025

10.  Major histocompatibility complex haplotypes and complement C4 alleles in systemic lupus erythematosus. Results of a multicenter study.

Authors:  K Hartung; M P Baur; R Coldewey; M Fricke; J R Kalden; H J Lakomek; H H Peter; D Schendel; P M Schneider; S A Seuchter
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.